524516 — Bacil Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹241.13m
- IN₹286.61m
Annual cashflow statement for Bacil Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -38.6 | -1.02 | -0.59 | 4.08 | 0.389 |
| Depreciation | |||||
| Non-Cash Items | -0.576 | -0.294 | -0.294 | -0.239 | -5.65 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.951 | -0.188 | 0.835 | 0.164 | 12.4 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -40.1 | -1.47 | -0.029 | 4.01 | 7.12 |
| Capital Expenditures | 0 | 0 | 0 | — | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 38.1 | -1.16 | 0.784 | 3.37 | -23.8 |
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 38.1 | -1.16 | 0.784 | 3.37 | -23.8 |
| Financing Cash Flow Items | — | — | — | — | -6.19 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.27 | 0.628 | -0.628 | 20.8 | -6.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.31 | -2.01 | 0.127 | 28.2 | -22.9 |